PD-1 and PD-L1 prognostic in UTUC

被引：0
|
作者：
Louise Stone
机构：
来源：
Nature Reviews Urology | 2017年 / 14卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：518 / 518
相关论文
共 50 条
  • [31] Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
    Diggs, Laurence P.
    Hsueh, Eddy C.
    BIOMARKER RESEARCH, 2017, 5
  • [32] PD-1 and PD-L1 blockade in gastrointestinal malignancies
    Lote, Hazel
    Cafferkey, Catherine
    Chau, Ian
    CANCER TREATMENT REVIEWS, 2015, 41 (10) : 893 - 903
  • [33] PD-1/PD-L1 Inhibitors in Cervical Cancer
    Liu, Yuncong
    Wu, Li
    Tong, Ruizhan
    Yang, Feiyue
    Yin, Limei
    Li, Mengqian
    You, Liting
    Xue, Jianxin
    Lu, You
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [34] Mechanisms of Resistance to PD-1 and PD-L1 Blockade
    Nowicki, Theodore S.
    Hu-Lieskovan, Siwen
    Ribas, Antoni
    CANCER JOURNAL, 2018, 24 (01): : 47 - 53
  • [35] PD-1 AND PD-L1 EXPRESSION IN OVARIAN CANCER
    Wieser, V.
    Gaugg, I.
    Fleischer, M.
    Fiegl, H.
    Marth, C.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 64 - 64
  • [36] PD-L1/PD-1 Axis in Glioblastoma Multiforme
    Litak, Jakub
    Mazurek, Marek
    Grochowski, Cezary
    Kamieniak, Piotr
    Rolinski, Jacek
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (21)
  • [37] Conventional chemotherapy combined with PD-1/PD-L1
    不详
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2023, 16 (SUPPL 3) : 60 - 63
  • [38] PD-1 and PD-L1 expression in cardiac transplantation
    Bishawi, Muath
    Bowles, Dawn
    Pla, Michelle Mendiola
    Oakes, Faye
    Chiang, Yuting
    Schroder, Jacob
    Milano, Carmelo
    Glass, Carolyn
    CARDIOVASCULAR PATHOLOGY, 2021, 54
  • [39] New Era Beyond PD-1/PD-L1
    Paz-Ares, L.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S127 - S127
  • [40] Antagonists of PD-1 and PD-L1 in Cancer Treatment
    Lipson, Evan J.
    Forde, Patrick M.
    Hammers, Hans-Berg
    Emens, Leisha A.
    Taube, Janis M.
    Topalian, Suzanne L.
    SEMINARS IN ONCOLOGY, 2015, 42 (04) : 587 - 600
12345